Indication: 1. Supplement the lack of estrogen in the body, such as atrophic vaginitis, female gonadal dysgenesis, menopausal syndrome, senile vulvar dryness and vaginitis, primary ovarian agenesis after oophorectomy. 2. Breast cancer, postmenopausal and male advanced breast cancer, those who cannot undergo surgical treatment. 3. Prostate cancer, advanced patients who cannot undergo surgical treatment. 4. Prevent postpartum lactation and milk withdrawal (or relapse).

Indication: 1. Supplement the lack of estrogen in the body, such as atrophic vaginitis, female gonadal dysgenesis, menopausal syndrome, senile vulvar dryness and vaginitis, primary ovarian agenesis after oophorectomy. 2. Breast cancer, postmenopausal and male advanced breast cancer, those who cannot undergo surgical treatment. 3. Prostate cancer, advanced patients who cannot undergo surgical treatment. 4. Prevent postpartum lactation and milk withdrawal (or relapse).

Indication: 1. Supplement the lack of estrogen in the body, such as atrophic vaginitis, female gonadal dysgenesis, menopausal syndrome, senile vulvar dryness and vaginitis, after oophorectomy, primary ovarian agenesis. 2. Breast cancer, postmenopausal and male advanced breast cancer, those who cannot undergo surgery. 3. Prostate cancer, advanced patients who cannot undergo surgery. 4. Prevent postpartum lactation and milk withdrawal (or relapse).

Indication: 1. Supplement the lack of estrogen in the body, such as atrophic vaginitis, female gonadal dysgenesis, menopausal syndrome, senile vulvar dryness and vaginitis, after oophorectomy, primary ovarian agenesis. 2. Breast cancer, postmenopausal and male advanced breast cancer, those who cannot undergo surgery. 3. Prostate cancer, advanced patients who cannot undergo surgery. 4. Prevent postpartum lactation and milk withdrawal (or relapse).

Indication: 1. Supplement the lack of estrogen in the body, such as atrophic vaginitis, female gonadal dysgenesis, menopausal syndrome, senile vulvar dryness and vaginitis, after oophorectomy, primary ovarian agenesis. 2. Breast cancer, postmenopausal and male advanced breast cancer, those who cannot undergo surgery. 3. Prostate cancer, advanced patients who cannot undergo surgery. 4. Prevent postpartum lactation and milk withdrawal (or relapse).

Indication: Acute leukemia and malignant lymphoma, breast cancer, bronchial lung cancer, ovarian cancer, Wilms tumor, soft tissue sarcoma, bladder cancer, testicular cancer, prostate cancer, gastric cancer, liver cancer (including primary hepatocellular carcinoma and metastatic cancer) and medullary thyroid cancer and other solid tumors.

Indication: Acute leukemia and malignant lymphoma, breast cancer, bronchial lung cancer, ovarian cancer, Wilms tumor, soft tissue sarcoma, bladder cancer, testicular cancer, prostate cancer, gastric cancer, liver cancer (including primary hepatocellular carcinoma and metastatic cancer) and medullary thyroid cancer and other solid tumors.

Indication: 1. To supplement the lack of estrogen and treat female hypogonadism, amenorrhea, menopausal syndrome, etc.; used for the treatment of advanced breast cancer (postmenopausal women) and advanced prostate cancer; used in combination with progesterone drugs, it can inhibit ovulation and can be used as a contraceptive. It is mainly used clinically as an ovulation inhibitor; it is also used for cryptorchidism and androgen excess in children, pituitary tumors, etc. It is used to diagnose hypothalamic-adenohypophysial-gonadal dysfunction, which can be based on changes in gonadotropin and sex hormone levels. 2. To treat amenorrhea and infertility caused by hypogonadism due to insufficient secretion of gonadotropin, and infertility of multifollicular ovary. For amenorrhea related to weight loss, the weight should be corrected by diet first. It is also used for prostate cancer (often used in combination with cyproterone acetate or fluazifop), delayed or early puberty, and endometrial dysplasia. Main